tm logo

Monitor this mark

View On USPTO

ELOCTATE
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 12 Aug 2021

Last Applicant/ Owned by

BIOVERATIV THERAPEUTICS INC.

225 SECOND AVENUE

WALTHAM

MA

02451

Serial Number

85411822 filed on 31st Aug 2011

Registration Number

4645453 registered on 25th Nov 2014

in the Principal Register

Correspondent Address

Karen Lim

Karen Lim

151 West 42nd St., 17th Floor

New York NY 10036

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

ELOCTATE

Pharmaceutical preparations for the treatment of hemophilia

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for the treatment of hemophilia

First Use Date in General

14th Jul 2014

First Use Date in Commerce

14th Jul 2014

Mark Details

Serial Number

No 85411822

Mark Type

No Service/Collective Mark

Attorney Docket Number

No BIOV 1912577

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
25th Nov 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
12th Aug 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12th Aug 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
12th Aug 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
15th Apr 2021TEAS SECTION 8 & 15 RECEIVED
25th Nov 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
10th Oct 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10th Oct 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
22nd Feb 2017AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
14th Feb 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED